Jim Cornall

biotech

Hand-held probe maps cancerous tissue

biotech

Cells “back up” DNA replication to survive damage

biotech

Base to Base biotech podcast 58: Congenital myotonic dystrophy

biotech

Researchers discover new therapeutic targets for lithium in Alzheimer’s disease

biotech

New research brings personalised treatment for Parkinson’s disease closer

biotech

Greywolf Therapeutics and Genomics look to develop first‑in‑class autoimmune diseases treatments

biotech

Priority review for potential first approved treatment for warm autoimmune haemolytic anaemia

biotech

New first-in-class therapy for chronic graft-versus-host disease approved in Australia